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Introduction: Significant problems in clinician-patient communication have been described in the
oncology literatures. Advanced stage non-small lung cancer, a devastating disease, can cause the
communication between survivors, significant others, and clinicians tofalter To date, however, no
studies have used qualitative methods to examine experiential aspects ofliving with non-small cell
lung cancer Norhave anystudies evaluated the tools survivors mightuse to repairsome ofthe dam-
age caused by living with this disease.
Methods: Exploratory, two-part qualitative design.
Results: Survivors ofnon-small cell lung cancer live with multiplefears and losses. These include
a diminished sense ofself, the loss ofhealth,fears ofpain in afuture tainted by the threat ofdeath,
and increasedfeelings ofalienation due to the loss ofprevious sources ofmeaning in life. These
experiences significantly affect cancer survivors abilities to communicate with clinicians and sig-
nificant others.
Conclusions: Survivors ofnon-small cell lung canceroften have difficulty sharing their experiences
with others notsuffering a similar affliction. Through their narratives with other survivors, howev-
er, patients are better able to initiate a biopsychosocial mechanism which enables them to create a
cognitive map. This cognitive map helps survivors share their experiences with others, thereby
repairing some ofthe damage caused by this disease, including the harm done to their communica-
tion with otherpeople.
INTRODUCTION
Lung cancer is the leading cause of
cancer-related death around the world and
in the United States, 164,100 new cases
and 156,900 deaths occurred in the year
2000 [1]. The majority oflung cancers are
non-small lung cancers (NSCLC)d [1].
NSCLC is almost always caused by expo-
sure to tobacco, including active cigarette
smoking, pipe and cigar smoking, and
exposure to second-hand smoke (passive
smoking) [2]. Other factors known to
increase individual susceptibility to lung
cancer include various occupational expo-
sures (e.g., radon and asbestos), diet, gen-
der, and genetic susceptibility [2-3]. Since
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no test provides adequate early detection,
and symptoms are generally not present
(except in the advanced stages ofdisease);
patients are generally diagnosed with
advanced-stage or metastatic disease (i.e.
stage IIIB and stage IV) [2]. Treatments
for advanced stage disease are rarely "suc-
cessful." Thus few advanced stage NSCLC
survivors are successfully "cured," or
experience an extended disease-free sur-
vival time, as the majority ofpatients who
undergo curative resection will develop
recurrent metastatic disease within five
years of their initial diagnosis [2]. Five-
year survival rate combined for all stages
ofdisease is approximately 14 percent [2].
Due to a generally grim prognosis, toxic
treatment regimens, physical morbidity,
and poor survival time-rates, patients with
advanced staged NSCLC understandably
experience far greaterdistress and feelings
of alienation than survivors with other
advanced tumours [4-5]. This includes dif-
ficulties sharing their experiences with
other people [6-10].
In this paper, we suggest that NSCLC
exacerbates a disruption between the
mind, body, and the social world of the
individual with cancer, a breach often
reflected in a crisis in communication
between clinicians and patients, as
NSCLC survivors' experiences seemingly
defy language. These communication
problems stem from the lack of common
overlap between language and experience,
since others who exist outside the experi-
ence of NSCLC invariably fail to fully
grasp the impact and meanings of this
experience on the NSCLC patient who
suffers [6, 11]. Nonetheless, narratives can
assist in the mending of this breach
because they can aid the patient in a
process whereby psychosocial and physio-
logical experiences can be integrated into
the patient's life [6, 11-12]. In this manner,
clinicians can use what they learn from
NSCLC survivors' narrative accounts of
illness as a means of decreasing psycho-
logical morbidity, including patient's feel-
ings of being diminished by cancer, the
despair, distress, and social isolation that
is often characteristic of living with
NSCLC. In addition, we also describe how
this process of repair through narrative
could potentially initiate a biopsychoso-
cial mechanism, which begins when a
NSCLC survivor seeks social support for
their illness from other survivors. Through
a complex process oflearning, patients are
better able to develop a cognitive map.
This cognitive map, because it provides
the survivor with a framework of what to
expect from treatments, enhances a
NSCLC survivor's ability to understand
their own experiences articulated and mir-
rored through the lens of other survivors'
experiences. As a consequence, NSCLC
survivors are better able to narrate their
concerns and share these experiences with
other people, including their caregivers.
LITERATURE REVIEW - ISSUES
THAT AFFECT COMMUNICATION
WITH ONCOLOGY PATIENTS
A review of the literature demon-
strates that a variety of communication
problems affect the care of oncology
patients. The majority of these however,
tend to over emphasize phenomena such
as the medical interview and the breaking
ofbad news as focal points ofinquiry [13-
19]. These studies suggest that "oncology
as a social practice" exacerbates problems
in clinician-patient communication
because delivering news about the cancer
diagnosis, treatments, and metastases can
cause the dialogue to falter. Other impor-
tant barriers to effective clinician-patient
communication have also been recently
identified [20-23]. These physician-related
barriers include the unwillingness to deal
with the unrealistic expectations for "cure"
on the part of patients [13, 17-19, 23-29].
Time constraints in seeing survivors and
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and emotional concerns [28, 30-32] and
the lack of communication skills-training
of clinicians [17, 20, 32, 34-35]. Patient-
related barriers include poor communica-
tion skills by patients who may be unreal-
istic. A lack ofinvolvement in the medical
discussion of care, including inadequate
information and expectations about what
to expect from treatments and post-treat-
ments as these impact health-related and
global quality of life [17, 20, 32, 34-35].
The patient's inability to accurately recall
information [18, 28, 29]. And finally, pat-
terns of communication between cancer
patients and clinicians may be disrupted
by the patient's fear that related symptoms
such as pain signify a return, or spread, of
the cancer, serving as a premonition of
death from this disease.
In this paper, we argue that the
impaired communication between the
clinician and the NSCLC patient that gen-
erally occurs due to the absence of a
shared language and cultural experience
can be partially mended through narrative.
However, to begin to understand the ori-
gins of this impaired communication, we
suggest a broadening of the definition of
what communication means in states of
health and illness. Implicit in this broader
definition is that in states of health, all
information from the external environment
is communicated to and transformed into
neural processes, ensuring the proper reg-
ulation of immune function in both brain
and body, such that a relative state of
homeostasis (health) is maintained [36,
38, 40-41]. Thus, the long-term process
leading to the appearance of cancer, and
the disruption of communication in terms
of neuro-immune function is susceptible
to modulation and modification by both
endogenous (internal to the organism) and
exogenous (external to the organism) fac-
tors, such as stress [36-38]. In response to
immune challenges, certain lymphoid cells
produce proteins, or cytokines, mediating
various immune signals to the brain [40-
41]. The brain then sends neurotransmitter
and hormone-mediated signals via the
autonomic nervous system and the pitu-
itary-endocrine axis respectively. The
hyperactivity of the hypothalamic-pitu-
itary axis (HPA), a typical response to
stress, induces increased production of
stress-related hormones, such as cortisol,
which then serve to either modulate the
immune response, or possibly indirectly
activate oncogenes by HPA axis hormones
[39-41]. Nonetheless, while important evi-
dence exists that could partially explain
important transitions from health to illness
in the human system at the molecular
level, other research must also begin to
understand the related social processes
that broadly affect patterns ofcommunica-
tion between clinicians and cancer
patients. These include understanding the
emotional, existential, and psychological
paths that patients must take as they
endeavor to make sense of their experi-
ences with advanced-staged disease, and
perhaps most significantly, how they adapt
and communicate these experiences and
concerns with other people.
SOCIAL SUPPORT
Human beings generally continue to
learn and integrate information at all ages
due to their social, cultural, historical, and
emotional interactions with other people.
Indeed, supportive interactions have been
shown to modulate neuro-immune func-
tion in both healthy controls and in cancer
patients [40-41]. Psychosocial interven-
tions, emphasizing social support in the
context of cancer support groups, have
yielded improvements in fighting spirit,
reductions in helplessness, anxiety,
depression [40-41], enhanced satisfaction
in life, communication and a decrease in
anxiety, and distress [8-11, 40-44].
One of the central tenets of social
support in the context of oncology is that
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illness situated in the context of their life
experiences with others who are similarly
afflicted. This is because narrative is cru-
cial to the process ofrecognizing and inte-
grating repressed and alienated selves that
suffer since it is one of two fundamental
modes ofcognitive functioning [45-46]. In
contrast with paradigmatic thinking,
which emphasizes formal categorization,
narrative thinking emphasizes the struc-
turing ofevents in terms ofthe human cal-
culus of actions, thoughts, and feelings
[45]. Narrative is also an important tool
that can be used to probe, resurrect and
forge connections between unstable, situ-
ated selves in the context ofillness [46], as
over time the patient can begin to express
their feelings in a supportive context
where their unique encounters with illness
can be understood. Feeling understood,
the cancer survivor ideally begins to build
a cognitive structure over time that sup-
ports a bridge between the memories and
images of who they are, with who they
have been, and who they might realistical-
ly become as they go through treatments
and beyond. Social support through the
medium of narrative then works to begin
to systematically repair some unknown
portion of the neuro-immune link, which
had previously extensively engaged in
interactions between the internal and the
external environment prior to illness. This
repair, initiated by the cancerpatient in the
context of socially supportive encounters,
serves to reconcile certain disparities in
the individual body/self as situated in a
social context of the illness. In this man-
ner, patient's narratives not only give
shape to their experiences with NSCLC
cancer as they provide the patient with a
language for their experiences but also a
language to communicate and share
aspects of these experiences with other
people. In this way, patients' narratives
can also aid the clinician as they attempt
to understand the underlying cognitive
processes, motivations, and cultural
frameworks that inform human thought
processes across culturally diverse cancer
patient populations [47].
METHODS
The product of a qualitative study is a
narrative [48]. To address these important
concerns, we designed a two-part qualita-
tive study. Qualitative research can be
defined as the process of summarizing and
interpreting data to develop theoretical
insights that describe and explain social
phenomena such as interactions, experi-
ences, roles, perspectives, symbols, and
organizations. In terms of health care
analysis, qualitative research can also offer
insight into the emotional and experiential
phenomenon to define the whats, hows,
and the whys of everyday life experience.
Examples include inquiry about the multi-
ple meanings of illness to patients and
their families, or about the attitudes and
behaviors that affect dynamics between
patients and clinicians.
The initial phase of this qualitative
study (i.e., November 1998 through
February 1999) sought survivors' under-
standings of lung cancer treatments, and
related symptoms, including pain, distress,
alienation, and cognitive dysfunction.
What emerged from these early interviews
was the observation that the majority of
patients enrolled in our study also
described a loss of self due to the difficul-
ties entailed in describing and sharing their
experiences with others that did not also
have lung cancer. Therefore, to better
understand these barriers to communica-
tion, we designed a second part of the
study (March 1999 until November 2000).
This part ofthe study was designed to fur-
ther evaluate the potential role of sur-
vivor's narratives as a vehicle to communi-
cate their experiences with others and as
an attempt to repair some of the damage
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We are not aware of any studies that
have ethnographically explored narrative
accounts of patients' experiences with
NSCLC. Because this was a pilot study,
and previous reports were unavailable to
suggest what concerns NSCLC survivors
might have on the subject, interviews fol-
lowed an open-ended semi-structured for-
mat. This format allowed specific ques-
tions to be asked of each patient and also
permitted each patient to contribute infor-
mation that was important to them.
Interviews lasted one and one-half to four
hours and were conducted and tape-
recorded either at the cancer center or over
a meal. It seemed appropriate to conduct
open-ended, semi-structured interviews
rather than to administer a fixed response
questionnaire since this helped to prevent
a distortion of patient's responses by the
researcher and allowed for the emergence
of unanticipated findings. Subjects spoke
about their diagnosis, their feelings about
having advanced-stage NSCLC cancer, its
effects on their social and family lives,
social support, medical and family histo-
ries, and their perceptions of how they
were treated by health professionals. After
transcribing and then reading the inter-
views, cases were coded by categories,
themes and patterns. By situating these
narratives in the context of their lives, the
goal was to remain faithful to what these
survivors meant as they described their
experiences. The interview questions are
listed in Table 1. This qualitative analysis
is based on approximately 150 hours of
interviews.
Sample
The investigators received approval
from the institutional review boardprior to
the beginning ofthis study. To explore the
broad experience of living with NSCLC,
we conducted a two-part study. Twenty-six
survivors with advanced-staged NSCLC
were recruited and interviewed for this
study between November 1998 and
November 2000 at The University of
Texas M.D. Anderson Cancer Center in
Houston, Texas. Because NSCLC has such
a high recurrence rate, we chose to speak
with survivors across all phases of disease
experience: from the newly diagnosed
patient making treatment decisions, to the
patient undergoing chemotherapy, and to
the long-term cancer survivor. Survivors
with advanced-stage (Stage IIIB, Stage
IV) NSCLC 2 were recruited with the
assistance of a medical oncologist. All
patients who were approached decided to
participate in this study. Informed consent
was collected at this time.
RESULTS
Themes
Three major themes affecting patterns
of communication were described in the
first part of this study. These were: loss of
the illusion of life and health, including
how the self was diminished by the cancer
experience, fears about pain and a future
colored by the threat of death, and finally
an increase in feelings ofalienation, due to
an inability to adequately share these
experiences with others. These themes
highlight the difficulty of living with
NSCLC. During interviews, patients spoke
about how alone they felt, how the diagno-
sis had disrupted their lives, and their
desire to speak with other NSCLC sur-
vivors who were also struggling with this
disease. In the interviews, patients also
spoke about how their experiences signifi-
cantly (and often negatively) affected their
ability to communicate with clinicians and
significant others who had not shared sim-
ilar experiences of disruption. The second
partofthis study focused on how survivors
described the cultural and cognitive
process of becoming an expert to gain
greater insight into whatNSCLC survivors
did to repair some of the damage caused
by this disease.372 Moore et al.: Communication problems in advanced non-small cell lung cancer
Table 1. Participant questions.
Questions for Part 1.
1. Where are you from? How did you find out that you had lung cancer? When were you
diagnosed? Did you have any symptoms?
2. Is this your first encounter with NSCLC? Did you ever have cancer before?
3. What did you know about lung cancer prior to your diagnosis? And now?
4. What did hearing that someone had cancer mean to you? Before cancer? Now?
5. At what age were you diagnosed with any cancer? What stage?
6. How do you remember your doctor/nurse telling you that you had cancer? How did you
feel cancer? What do you remember about the experience? Did you let your family
know? Who did you tell? Did you detect that people treated you differently as a
consequence of knowing that you had cancer?
What was your treatment regimen? Number of weeks/cycles?
Surgery Radiation_
Chemotherapy_ _ Other
7. What discomforts if any did you experience during your treatments? Hair loss? Fatigue?
Did you feel any pain?
8. What would you say were the more painful aspects of your experience? How would you
describe them?
9. Before the treatment? During? Now? Can you separate out the different aspects of the
experience? Describe the pain? Was itjust a physical sensation? Emotional? Spiritual?
Questions for Part II:
1. Do you talk with other people about lung cancer? Have you noticed any problems com-
municating that you have NSCLC to other people? If so with whom did you talk; if not
why not?
2. Recently there has been a lot in the literature suggesting that more women are living
longer and surviving lung cancer - how has this emphasis on lung cancer in the news
effected your life? Your relationships?
3. Did you ever feel alone in this experience?
4. What did you do to get over this feeling?
5. Did you talk with a counselor, or therapist?
6. Did you talk with other survivors of NSCLC? At what point in your treatment did you talk
with other survivors? How did this experience change your life
7. What does life mean to you now? And if there has been a change, how has it changed?
Loss ofan illusion ofhealth and oflife
A diagnosis of advanced-stage
NSCLC, debilitating treatments, the contin-
uedthreatofpain anddeathis always adev-
astating experience, causing personal,
social and psychic disruption in advanced-
stage NSCLC patients. Similar to previous-
ly described quantitative studies on this
subject, [5, 8-9] upon being interviewed;
NSCLC survivors described their losses,
fears ofpain, they articulated how NSCLC
diminishedtheir sense ofself, andthe threat
ofdying; amidst these increased feelings of
alienation [49]. Still others expressed fears
ofsuffering, that they would die alone, orin
pain from this disease.Moore etal.: Communication problems in advancednon-small cell lung cancer 373
In an account ofbeing suddenly faced
with the loss of health, a grim prognosis,
and a loss of life, Anna Ye, a 39-year old,
Asian-American computer engineer, who
was diagnosed in June, 1999, with Stage
IV NSCLC stated:
I am only 39 years old. I started to have
some wheezing and some blood in my spit. I
could not breathe, and on June 11th - I will
never forget that day. I had an x-ray and the
results were not good. I was sent to the lung
specialist. He did abiopsy. I did not appreci-
ate his bedside manner. This doctor deliv-
ered the news while I was flat on my back
tubes everywhere and he just dumped it on
me. He said, Ms. Ye, even though I am mar-
ried, I whispered yes, he said it is lung can-
cer, and it has spread. Then he looked away.
He never looked into my eyes. He was very
precise, and his time with me was very brief
and very short. I cried, and then he was
gone. He never even looked at me. On June
16th I came here. On the 28th I started
chemo on July 2 till now. We got books
about this disease but for a while nothing
sunk in. Reading about NSCLC especially
before 1997, you read it and you know you
are going to die. All the protocols are scary.
I used to get panic attacks you know I was
afraid to sleep. I sometimes think I will not
wake up. Some days I am hopeful but on
other days...I am only 39, what did I do to
deserve this?
William Johnson, a white, 63 year old
farmer and 8-month survivor of Stage IV,
NSCLC described a similar reaction to his
diagnosis. He began:
I was diagnosed on April 8, 1999. I went
from health to this. Five-bypass surgeries
and they find a spot on the X-ray. I had the
surgery and then had these treatments. Four
different times after the first treatment I
wound up in the hospital. Heart problems,
low blood sugar, a severe rash, and I vomit-
ed for two days. Two weeks later all my hair
fell out, my nails hurt, my bones ached, I
was so tired, I could not eat a thing, and I
could barely breathe. I have worked all my
life to retire to be with her (refers to wife).
She used to work in a sweatshop sewing
clothes. She just retired. We wanted to be
together, and now I can't breathe and I feel
like there is no time left.
In a related story, Paul Roberts, a
white 67-year old male, was initially diag-
nosed in 1994 with a stage II tumor.
Accompanied by his wife in clinic in
1999, he described in what had become a
very raspy voice, not only finding out that
he had cancer, but that his cancer had
retumed. He began our interview by stat-
ing how he woke one day spitting up
blood. Then he claimed:
I had felt fine for some time but in the bath-
room I noticed I spit bloody saliva into the
sink. I spit up blood for a couple of days. I
went on a vacation, spitting up blood. I
smoked for 41 years and yes I was aware of
the risk factors. I was and am clinically
depressed. I got back from vacation, still
spitting blood and I saw the internist and
thought it would be ok. They got a chest X-
ray. Found out it was cancer. This made my
depression real bad. So I asked how long
have I got? Twenty-five percent chance of
living? Two years right? Before this you
know I was an international banker. I man-
aged otherpeople's money. Numbers matter.
I saw the surgeon, stage I, operated on in
July 1994. My right lung is two-thirds ofthe
way gone. I almost died in the intensive care
for 10 days. I never saw a medical oncolo-
gist, no radiation oncologist, just Dr. Faher
every six months. All was fine till it came
back that first time in March 1997. Saw a
shadow. Left lung filled with cancer. Left
lung this time. I went to all these places.
Everyone said ok let's operate. They opened
me up in June and seems like soon after I
went to sleep and opened my eyes it was
noon. They had only started at 7am. The
doctor told me they couldn't get at it since it
was too extensive.
While most survivors spoke about this
painful and often dramatic transition from
health to illness, others reported feeling
stigmatized, claiming that they didn't
understand why physicians and other med-
ical professionals were so obsessed with
their smoking behaviors. Sarna, in one of
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issues faced by survivors of lung cancer,
noted that despite some modest advances
in treatments for primary disease that the
attitudes ofclinicians have not altered rad-
ically, which is another psychosocial fac-
tor in treating survivors with this disease
[5]. NSCLC survivors also often reported
that clinicians were also quite judgmental
if they perceived that the survivor still
smoked, reflecting perhaps the significant
amount ofburnout and frustration ofclini-
cians treating survivors in this population
[49]. They often also reported that there
was limited sympathy for them, since they
were seen to have caused their disease.
This might be why William Johnson, the
63-year old, retired farmer, made it his
personal agenda to tell the research nurse
who asked him about his smoking history,
how he felt. In a biting critique of being
stigmatized, he exclaimed:
You know, not everything needs a reason. I
mean you have tons of folks whom never
smoked and got lung cancer. And tons who
did and never got lung cancer. And then you
got me I smoked and I got lung cancer. So
what! I chewed cigars and smoked for 26 or
28 years. What caused this, my doc said bad
luck, bad genes, or it could have been the
farm chemicals, who knows, and who cares.
I got it so why do you all ask that does it
really matter? Is that all you care about?You
know, not everything needs a reason. You
just concentrate on curing me ok.
Fears ofcancerand relatedpain
Clinical perspectives and survivors'
expectations and experiences often differ,
particularly in terms of the mental and
emotional effects ofthe experience ofcan-
cer and related pain [10], the language
used to describe pain, and controlling,
understanding and alleviating the suffering
it causes. Pain is a synonym for a variety
of symptoms. Unrelieved pain increases
the suffering of the survivor [50] and an
increase in pain (based on survivor self-
report) in advanced-stage NSCLC in one
major study was associated with a 27 per-
cent increase in death [51]. As pain is a
synonym for a variety of other symptoms,
survivors universally described their pain
in terms of feeling diminished by lung
cancer, and in their decreased hopes for a
decent quality of life. Others found it dif-
ficult to think about the possibility of a
future in the advanced stages of their ill-
ness. Often, when survivors experienced
any pain that seemed different than "nor-
mal," they feared that their tumormight be
growing at an exponential rate. The major-
ity also felt alone with their pain. The
experiences of Amos Night a 73-year-old
African American man, who was diag-
nosed with Stage IV NSCLC in Octoberof
1999, highlight these previous points. He
noted:
I am afraid I will neverget well. When I hurt
I am afraid it's growing. My brother is here
and yet I am still alone. The coughing, the
tiredness just never ends. See all that cough-
ing (he coughs). Nothing comes up. This is
never going to end till I die is it? You know
mine began as cough pain and weight loss. I
was initially diagnosed with bronchitis. I
was diagnosed with cancer three months
ago. I keep coughing and I am sick. I amhalf
way through chemo and half way through
radiation. I had pneumonia and I was in the
hospital for 18 days. I am tired all the time.
I cough constantly. The doc says its just
pressure but I consider it pain. I hear echoes
in my hearing because of the cisplatin. I
can't seem to do nothing right. My life has-
n't changed at all except I am scared and
sick all the time. This fear, you know, it
wraps around a body. I am scared of all this
pain and scared I will die coughing. Do you
know what that feels like, like you are
breathing and itends in acoughcaught short
in the breath. Life is not more precious now
and it never was. But I amjust scared Iwon't
live to find out.
To visit the possibility of the allevia-
tion of his pain and suffering, Mr. Night
asked questions that the clinician cannot
generally answer. What we also learned
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similar fear. This fear was that at the end
of their lives, they would die in agony
from cancer-related pain, and that their
pain would not be effectively controlled,
nor would their suffering be adequately
relieved. As a consequence of these expe-
riences, patients also feared that they
would no longer be the persons they had
been in any recognizable form. Research
studies show that their fears are quite
grounded, since the majority of cancer-
related pain remains under diagnosed and
too much cancer pain goes untreated [50,
52-53].
Cheryl Hopkins was a white, 56-year
old woman who was initially diagnosed
with Stage I adenocarcinoma of the lung.
Speaking as a three-year survivor, recently
diagnosed with metastatic disease that had
spread to the bone; her particular experi-
ences of living with NSCLC were also
aggravated by persistent pain, which sig-
nificantly contributing to her limited inde-
pendence, decreased function, and an
overall diminished quality of life. During
one extremely long episode of pain,
Cheryl articulated the dominance of pain
on her life. She began:
You know I no longer remember what it is
like to not be in pain. I can't think of any-
thing else but the pain and I can't concen-
trate at all. It has been like this for two years.
I have pain all over, under the cuff of my
right arm, the doctor calls it sub-clavicle
pain, and on my arm. I am on a break from
Taxol. I have three weeks off. I have lost
time because of pain. I have pain that
increases when I have chemo and I have pain
that increases when I don't have chemo. I
am damned. I have no taste anymore
because of this. I am so tired, I hurt and my
pain is barely controlled. I can't explain it. I
lose my train of thought all the time, I have
no life but I try to stay upbeat. I ask why. I
am religious but I still ask why all the pain
and I ask Jesus what did I do wrong? You
know I have asked him to take me, just now.
Sure I smoked for a few years. It has to be
environmental. I have grandchildren. I ask
Jesus what did I do to deserve all the pain. I
want him to take me. Do you understand me
at all? I am so unclear these days. You know
I am ready to leave this world. I can't con-
centrate at all. I can't take much more. My
husband cries all the time. He doesn't want
me to leave him. But I know I will. I can't do
anything else. I think about this all the time.
The dying. Most ofthe time I think about the
pain.
Cheryl's personal and social experi-
ence with NSCLC was intensified by unre-
lieved pain. It became understandably dif-
ficult for Cheryl to think or talk about any-
thing else. Cheryl had learned to expect
pain, a pain that could not be controlled,
due to the viciousness of a particular
tumor (pancoast tumor), which is general-
ly characterized by a widespread destruc-
tion to the rib, spine and severe neuropath-
ic pain. This type of pain is difficult to
treat through traditional drugs such as
morphine. As a consequence ofthis persis-
tent pain, Cheryl's life, body and self
became filled with pain. Moreover, over
time, she came to lack faith in anyone's or
anything's ability to adequately relieve her
suffering.
Alienation - a barrier to effective
communication
When we first met Mr. David
Robertson, a 64-year-old African-
American man, a retired construction
worker, and a three-year survivor of
NSCLC in January, 1999, he bluntly stated
that there are certain pains that you just
can't understand unless you have had can-
cer. He went on to say that there are just
certain aspects of the experience that you
(a person who does not have NSCLC) just
wouldn't get. Three months later, at a fol-
low-up visit to the clinic, he made a simi-
lar statement. We reminded him that he
said the same thing during ourinitial meet-
ings, and he merely smiled back and stat-
ed, "I meant what I said." Mr. Robertson's
remarks are similar to what literary schol-
ar Elaine Scarry claimed in her influential
text, The Body in Pain [ 1]. Scarry376 Moore etal.: Communication problems in advanced non-small cell lung cancer
describes howpain defies language, occur-
ring on a fundamental level of bodily
experience, which language encounters
attempts to express and fails to adequately
encompass. Due to a particular complexi-
ty, those who exist outside the pain experi-
ence often fail to grasp the significance of
these experiences on the sufferer [11]. So
how can the clinician effectively enter into
the NSCLC patient's experiential worlds,
so as to treat and effectively alleviate their
pain suffering? This seemingly no-win sit-
uation remains one ofthe majorbarriers to
the adequate management of cancer and
related pain.
Yet, another significant barrier to the
effective management of cancer pain is
rampant fears of addictions from the opi-
oids used to treatpain in advanced and ter-
minal cancer in the United States. These
fears exist across racial, class, and gender
lines on part ofsurvivors, family members
and medical professionals. We met Eleva
Michaels, a white, 44-year-old, indigent
woman initially diagnosed with Stage I
NSCLC. At the beginning of her treat-
ments, clinicians were sympathetic, at
least until they learned that Eleva also had
hepatitis B and C and was a recovering
drug addict, and that her liver was so dam-
aged from alcohol abuse that she was not
eligible for any chemotherapy protocols.
Due to her inability to get chemotherapy
and to keep her schedule for radiation,
within six months Eleva was diagnosed
with lung metastases to the bone (femur).
Though shehadreceived herprescriptions,
Eleva had none of her pain medication.
While she believed that her family had
stolen her pain medications, her accusa-
tions were often met with disbelief. In our
interview, she articulated how she had to
work extra hard to get her pain medica-
tions. She eloquently stated how this par-
ticular barrier, the stigma of addiction by
medical professionals, had also increased
her suffering. She asserted:
I came here today for a lung spasm. I had
three seizures and I again was sent to a sur-
geon for abiopsy. My right lung feels bigger
where my husband kicked me. I can't breath
and I hurt, all of me. Hurt both shoulders,
hurt left arm, hurt hand, my neck hurts all
the time. My head feels too heavy to hold
up. If I am off my pain meds I can't move
and I can't think. I am pain and it controls
me, everything I do, my activities, Ijust hurt
all the time. And I am unsatisfied with the
pain management 98 percent of the time. I
used coke and other drugs. I stopped, ok. I
think they fear I am still using that is why I
can't getrelief. I think thedocs don't believe
I aminpain. Thenurses' whisper andlook at
me with pity but I know they don't really
care. Bitches, to them I am just an addict
who may or may not have pain. They don't
believe me. Yeah I still smoke because it
calms me. I feel in control of this (points to
her cigarette) but not the pain. I am dying
why should I give up my one pleasure. You
know Ihave constant anxiety. I don't wantto
die but I will from this cancer. Sure people
are worried. My family says they care but I
had to drive myselfto this emergency room.
I am on morphine and I almost fell asleep at
the wheel. They give me no support. Who
really cares about me?
REPAIRING THE MIND-BODY LINK:
THE NARRATIVE PROCESS OF
BECOMING AN EXPERT
In describing the varying experiences
of living with lung cancer, one can clearly
see that there are few life experiences that
actually prepare a person to become a per-
sonal expert of a disease like NSCLC. We
can only presume how difficult it is for
someone outside these survivors' personal
worlds of suffering, to enter the language
oftheirexperience, so thatthey can gain an
in-depth understanding of these experi-
ences. Nevertheless, it is important that
NSCLC survivors attempt to share their
experiences with others, with those who
suffer from this disease, and with those
who witness their experiences. This shar-
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ly become engaged in a unique process of
learning to become experts of their illness
experiences.
The process ofbecoming an expert of
one's own disease involves a slow biopsy-
chophysiological process that is difficult,
uncertain, and occurs over time. One rea-
son this process seems to move rather
slowly (at least initially) is because it
involves the construction of a cognitive
apparatus based on lived experience, dedi-
cated to coping with a particular task, or
experience. The establishment of this
apparatus, or what we term "expertise,"
concerned with a familiar activity, comes
into existence in the brain through repeat-
ed practice and experience [59]. In addi-
tion, we suggest that it is the experience of
social support that could potentially acti-
vate a biopsychosocial mechanism where
psychological and physiological experi-
ences become integrated, thereby facilitat-
ing the transition from novice to expert.
Melzackhas described a similarprocess of
learning in terms of the pain experience.
He states that pain is a multidimensional
experience produced by a characteristic
neurosignature patterns of nerve impulses
generated by a wide distribution of neural
networks in the brain. All inputs from the
body undergo cyclical processing and syn-
thesis, so those characteristic patterns are
impressed on them in the neuromatrix.
The neurosignature as the outflow from
the body/self neuromatrix is projected to
areas of the brain and is transformed into
an ever-continual stream of awareness.
The experience of the body/self is thus
involved in multiple dimensions, such as
sensory, affective, physiological, etc.,
making a contribution to distinct portions
ofthe neurosignature [60]. Put differently,
a pattern-generating mechanism exists in
the brain that is capable of sustaining an
image of the body upon which sensory
data are played [61].
Similarly, in the experts memory
there is an amazingly comprehensive store
of partial and total configurations, which
allows the expert and not the novice to rec-
ognize a situation in an instant and know
what needs to be done next. One important
aspect of social support occurs when can-
cer survivors talkwith other survivors. The
sharing of their experiences of suffering
with other survivors provides a crucial
template that exponentially increases the
momentum of this process of learning on
the part of the survivor, making the
process of becoming an expert happen.
David Robertson described his process of
becoming an expert and beginning to
repair the disparity between his individual
body/self and the world of other people
through the experience of sharing and of
being understood by a survivor at the same
stage of disease. He began:
I was in pain all the time. Once I was in pain
so bad I had to go to the emergency room.
Then I had the nausea due to chemo and
diarrhea. I hadpain in my legs and since that
surgery I always had pain in my sides. It is a
throbbing pain. Last time I could not get out
of bed for two days after the last chemo. I
have come to expect the pain in my side
from the surgery. I know it but I have to try
and forget I have cancer to enjoy myself.
Sometimes I can and sometimes I can't but
at least I know that pain. What helped me
was one woman I met, had the same disease
I have, same stage, now she understood me.
We spoke of everything. What happened
when she was diagnosed? What she did for a
living? How shecould no longerwork? How
she felt and who she was? If there was a
future because at the time I met her she had
been alive two years. Two years with chemo.
Two years still coming in for treatments.
Two years alive. Two years with this thing.
Hard to imagine for you isn't it? It's true.
Now she is dead. But I am alive. And she
helped me cause she had felt and had the
same thing. Now she is dead. You know
there is no way to predict this cancer.
Anna Ye, also described what can be
considered as a similar process oflearning
to become an expert. She claimed:378 Moore etal.: Communication problems in advancednon-small cell lung cancer
My journey to cure still goes on. You know
what has been my shining light. Getting that
phone call from Matt Johnson. I called his
number. One week later he called me back.
He was diagnosed in 1995. Same stage.
Same disease. Ten years older. He had 30
weeks ofchemo and now he is fine. He calls
in to check on the drugs I am getting. He
calls to see how I am. He is an inspiration for
me because he sends a map of what he did.
A person with the same cancer. Non small
cell lung cancer. Alive, four years later. With
his map, I could live a long time. In my lung
cancer group we have a person with a one-
year remission. Knowing this gives me
strength to carry on. Just being there does
help. Knowing someone else who had this
and livedhelps. Even ifthey don't live along
time. It helps. It is not like chemo.
There is rarely a cognitive apparatus
in place to make immediate sense of the
experience of living with NSCLC.
Nevertheless, through experiences of
social support from other survivors,
through narratives of experience, multiple
forms of expertise through learning
emerge over time. Moreover as David and
Anna highlight in this process oflearning,
new symptoms and signs are compared to
one's own pre-existing cognition's in par-
ticular one's own prototypes for disease,
pain, or fatigue [62]. Images, sensations
and experiences of others are compared
and referenced within the context ofbuild-
ing an ongoing cognitive apparatus. Thus,
survivors become experts through learn-
ing, integration, and by sharing their cul-
tural, experiential, physiological, and cog-
nitive predicaments, which are unfortunate
consequences of living with advanced-
staged NSCLC. This shared understanding
of cognition and learning, broadens the
scope of control, serving as a means by
which "experts" can learn to cope with
new situations, both the easily recogniz-
able and the new and challenging, which
often come with this illness, expanding the
domain of what they had previously
learned to cope with efficiently [59].
Therefore, it is often through the narration
of their experiences that the individual
reconnects to others, their experiences of
living as survivors, merged with and mir-
rored by the experiences of other sur-
vivors, which builds a continually revised
cognitive and experiential map of survival
from NSCLC.
Limitations
There are several limitations in this
pilot study. Perhaps the most significant
one is that the number of study partici-
pants was small. Thus, until other studies
are completed on this subject, it will be
difficult to generalize these findings to all
patients with advanced-stage NSCLC. In
addition, this study only describes the
experience of living with NSCLC as it
affects communication on a variety oflev-
els of patients with NSCLC. Thus, only
one side ofthe story is revealed. While the
goal ofthis pilot study was to evaluate the
experiences of NSCLC from the patient's
perspective, future studies on this topic
should also evaluate the experiences ofthe
clinicians who treat NSCLC patients, and
perhaps the experiences of patients with
small cell lung cancers (SCLC) as another
comparison. This inclusion of clinicians'
experiences as well as the experiences of
patients with SCLC could also add to the
fruitful debate of clinician-patient com-
munication in oncology, and lung cancer
in particular. Furthermore, future studies
in this area might also expand upon the
study design by including an assessment
of biological variables (i.e., the measure-
ment ofdiurnal cortisol) and the quantita-
tive assessments of mood, depression and
anxiety in NSCLC patients. These vari-
ables have been shown to be of relevance
in analyses, which examine the plausible
link between social support, psychoneu-
roimmunology and survival time in
patients with advanced tumors [40, 41].
The addition of these variables could cer-
tainly build upon our study design, there-
by serving as a means to further validateMoore et al.: Communication problems in advanced non-small cell lung cancer 379
the plausibility of our findings.
Nevertheless, despite these apparent limi-
tations, valid aspects ofthese NSCLC sur-
vivors' experiences emerged in significant
ways that could enhance understandings
of clinician-patient communication in
oncology care, and of patients with
NSCLC.
DISCUSSION
The experience and struggle to live
with advanced-staged NSCLC is perhaps
best summarized by Dot Maklin, a 55-
year-old grandmother, maintenance work-
er, and a rare 11 year survivor NSCLC,
who upon being interviewed, powerfully
stated:
We all do what we can to survive. I have
lived 11-years with non-small cell lung can-
cer. I was diagnosed with brain and bone
mets. I was sent home to get my affairs in
order. Then I came here. But you see once
you've had lung cancer. Lung cancer. Well,
you think every ache, every pain is lung can-
cer. Youjust can't help it.
Advanced-stage NSCLC is clearly a
devastating disease, exacerbating a disrup-
tion between the mind, body, and the
social world of the individual cancer sur-
vivor. Because it is such a shattering expe-
rience, these patients often feel that they
are not understood, living as they do with
significant losses, impairments, fears of
abandonment, agonizing pain, and an
alienation caused by a self, diminished by
arduous treatments and the reality of
death. As a consequence, NSCLC sur-
vivors often find it difficult to describe
their experiences with others who do not
biologically, psychologically, and existen-
tially share their same experiences of can-
cer, pain, and suffering. This alienation is
caused by the struggle to live with
NSCLC, by the attempts to create a sense
of meaning out of the experience, and by
limitations in sharing the trauma of these
experiences with other people. It is this
very struggle that contributes to the
unmaking of language, the survivor's
social world, as they knew it, and the
meanings of their social reality. All of
these factors logically contribute to the
very real difficulties of communicating
with clinicians and significant others.
We began this paper by suggesting
certain possibilities in terms of how med-
ical researchers might begin to expand and
build upon how we have traditionally
looked at barriers to effective clinician-
patient communication in oncology. While
the majority of studies evaluating these
barriers tend to focus on the medical
encounterper se, we chose to begin with a
broader definition of communication on a
variety of levels, including its disruption,
at the level of individual biological and
neurological processes. From there, we
then suggested that the individual experi-
ence orencounter with cancer, while clear-
ly an individual experience, is also part of
a social process. The disruption in social
life or environment caused by this cancer
occurs on two levels. The first is repre-
sented by a breach in the communication
patterns within the individual patient. The
second level reflects the limits of the
patient's ability to effectively access acog-
nitive template to create a language to
share their experiences with others. Thus,
the significant distress, depression, and
alienation that have characterized NSCLC
patients, not only highlight the gravity of
this particular disease. It also draws atten-
tion to the limited tools that patients have
access to as they try to cope with and com-
municate some of the more dire conse-
quences of their experiences with others.
Finally, and perhaps most significantly, it
also directly points to a failure on the part
of oncology professionals to provide ade-
quate skills and social support, which
could potentially serve as a counter and
aid to this breach in communication
between advanced-stage NSCLC patients
and their caregivers.380 Moore etal.: Communication problems in advanced non-small cell lung cancer
The need to talk about experiences of
"surviving and coping" with NSCLC was
clearly prevalent in the patients who chose
to participate in this particular study.
Nonetheless, these patients need to devel-
op the skills and tools to communicate and
share their experiences with others. The
potential to structure narratives around
supportive encounters, such as support
groups that focus on the unique experi-
ences of being an advanced-stage cancer
survivor can aid the individual in their
attempts to repair some of the damage to
communication caused by this disease
[63]. Indeed, performance status, ofwhich
mood and affect are important and interre-
lated components, influence the course,
including the quality of survival in those
patients with advanced staged tumors [40-
41]. Narrative is, therefore, one important
tool working in concert with a variety of
other tools, which could potentially facili-
tate an important biopsychosocial mecha-
nism that could decrease the survivor's
sense of being diminished by this disease.
One important facet of this narrative
process involves seeking social support
from other survivors, which enables the
patient to create a cognitive map of emo-
tional and physiological experience. This
cognitive map, while shifting and chang-
ing over time and experience with this dis-
ease, alleviates some ofpatient's suffering
by assisting the survivor in learning to
become experts of their own illness expe-
rience. This transition between the private,
personal, indescribable experiences of the
pain and suffering of the novice to other
more social experiences via social support
creates expertise through language [10-11,
59, 63]. In turn, the ability to create acom-
mon language based on this experience
with others who similarly suffer legit-
imizes the survivor's experiences. The end
result is that these NSCLC survivors are
better able to share their experiences with
others, including their clinicians.
Additional work in this field lies in edu-
cating survivors about their options and by
listening to the wisdom of what NSCLC
survivors say, as they are ultimate experts
of their experiences. And finally future
work in this area mustcontinue to examine
these narrative processes, including their
roles in facilitating the multiple forms of
communication that are both expressed
and disrupted by the experience of living
with NSCLC.
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